The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...

U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive suggesting its research ...

A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations ...

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...

Pfizer will continue operating in Lee County after consolidating facilities. The move comes 18 months after Pfizer confirmed ...

The European Court of Justice Wednesday ruled there was no plausible reason to block the New York Times from getting European ...

The EU's General Court annulled on Wednesday a European Commission decision not to disclose text messages Commission ...

A top European court says the European Commission failed to provide a credible explanation for refusing The New York Times ...

After 6 months, placebo was associated with a mean weight gain of 0.4 kg (o.88 lb), compared with 1.2-1.9 kg (2.6-4.2 lb) ...

Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...

Take a look at hedge fund Starboard's equity moves in Q1, including halving its stake in Pfizer. Read more here.

For investors willing to look beyond the current negative sentiment, Pfizer at today's prices represents a rare buying opportunity.